Discontinued — last reported Q2 '19
Non-Current Assets
Equity Securities (FV-NI) - Non-Current
Amgen Equity Securities (FV-NI) - Non-Current decreased by 2.2% to $6.01B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.6%, from $5.48B to $6.01B. Over 3 years (FY 2022 to FY 2025), Equity Securities (FV-NI) - Non-Current shows an upward trend with a 96.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2018
Last reportedQ2 2019
Metric ID:
equity_securities_fvni_noncurrentHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $815.00M | $4.25B | $4.51B | $3.99B | $3.47B | $5.06B | $4.19B | $5.48B | $4.90B | $6.82B | $6.14B | $6.01B |
| QoQ Change | — | +421.5% | +6.2% | -11.7% | -12.9% | +45.7% | -17.2% | +30.9% | -10.7% | +39.2% | -9.9% | -2.2% |
| YoY Change | — | — | +453.9% | — | — | +19.0% | -7.2% | +37.6% | +41.2% | +34.8% | +46.7% | +9.6% |
Range$815.00M – $6.82B
CAGR+106.8%
Avg YoY Growth+79.4%
Median YoY Growth+36.2%
Current Streak2 quarters decline
Equity Securities (FV-NI) - Non-Current at Other Companies
Frequently Asked Questions
- What is Amgen's equity securities (fv-ni) - non-current?
- Amgen (AMGN) reported equity securities (fv-ni) - non-current of $6.01B in Q1 2026.
- How has Amgen's equity securities (fv-ni) - non-current changed year-over-year?
- Amgen's equity securities (fv-ni) - non-current increased by 9.6% year-over-year, from $5.48B to $6.01B.
- What is the long-term trend for Amgen's equity securities (fv-ni) - non-current?
- Over 3 years (2022 to 2025), Amgen's equity securities (fv-ni) - non-current has grown at a 96.1% compound annual growth rate (CAGR), from $815.00M to $6.14B.